Enteral Access Technologies raises €590k for medical device innovation
Also see more funding coverage: /funding/
Founded 2018 · Liverpool, United Kingdom
The European medtech sector continues its steady growth trajectory, with regulatory clarity around medical devices creating opportunities for innovative startups to scale across EU markets. Enteral Access Technologies has secured €590k in funding to advance its DoubleChek medical device platform, positioning itself within the growing market for patient safety solutions across European healthcare systems.
The funding round was led by the British Design Fund, which has increasingly focused on healthcare innovation companies that can leverage the UK’s regulatory expertise while expanding into broader European markets. This investment represents the Fund’s continued commitment to supporting medtech startups that address critical patient safety challenges through innovative design.
Medical device funding gains momentum in European healthcare
The British Design Fund’s investment in Enteral Access Technologies reflects a broader trend of UK-based investors supporting healthcare innovation companies that can navigate complex European medical device regulations. The fund, known for backing design-led companies, sees particular value in medtech solutions that combine engineering excellence with clear clinical outcomes.
“We’re backing companies that understand the critical importance of patient safety in healthcare delivery,” said a representative from the British Design Fund. “Enteral Access Technologies demonstrates the kind of innovative thinking that can make a real difference in clinical settings across Europe.”
The €590k investment positions Enteral Access Technologies to scale its DoubleChek platform, which addresses specific challenges in enteral feeding procedures. European healthcare systems increasingly prioritise patient safety technologies, creating a receptive market for solutions that can demonstrate clear clinical benefits and cost efficiencies.
Scaling across fragmented European healthcare markets
Enteral Access Technologies plans to use the funding to expand its commercial operations and enhance its DoubleChek platform for broader European deployment. The company’s approach to medical device development reflects understanding of the fragmented nature of European healthcare procurement, where solutions must adapt to varying clinical protocols across different national systems.
The medtech startup faces the typical challenges of European market expansion, including navigating different regulatory approvals and establishing relationships with healthcare providers across multiple countries. However, the company’s focus on patient safety solutions aligns with pan-European healthcare priorities, potentially smoothing market entry processes.
“Our vision is to make enteral feeding procedures safer for patients across European healthcare systems,” noted the company’s leadership team. “This funding enables us to scale our platform and work more closely with clinical teams to implement our solutions where they’re most needed.”
The investment in Enteral Access Technologies signals continued confidence in European medtech innovation, particularly for companies addressing specific clinical challenges with scalable technology solutions. As healthcare systems across Europe continue modernising their approaches to patient safety, companies like Enteral Access Technologies are well-positioned to capture growing demand for innovative medical devices.
